Welcome Guest! | login
US ES

MoatRx
Timeline
blog
forum

Activity Stream

MoatRx » Timeline » Timeline Update
MoatRx
@moatrx • one month ago
Posted a new blog:
US COLD AGGLUTININ DISEASE Competitive Intelligence
Sutimlimab is the only approved CAD therapy, yet 54% of patients met the composite hemoglobin-response endpoint against off-label rituximab. Cold agglutinin...

Tags

Dislike 0
You must be logged in to post a comment
MoatRx
View All
Followers:
bestcwlinks willybenny01 beejgordy quietsong vigilantcommunications avwanthomas audraking askbarb artisticsflix artisticflix aanderson645 arojo29 anointedhearts annrule rsacd
Recently Rated:
stats
Blogs: 120